Ratings by BofA Securities (Travis Steed)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/22/2022 Baxter International BAX Maintain Buy
(N/A)
 
 
  Details
6/21/2022 Embecta EMBC New Coverage Underperform
(N/A)
28.26
(26.08)
-7.71% Details
5/31/2022 Abbott Labs ABT Maintain Buy
(N/A)
 
 
  Details
5/27/2022 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
5/23/2022 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
3/23/2022 Inari Medical Inc. NARI New Coverage Buy
(N/A)
86.17
(68.66)
-20.32% Details
3/2/2022 Cardiovascular Systems CSII New Coverage Underperform
(N/A)
21.63
(14.57)
-32.64% Details
3/2/2022 Tandem Diabetes Care TNDM New Coverage Neutral
(N/A)
112.96
(61.81)
-45.28% Details
3/2/2022 Pulmonx Corp. LUNG New Coverage Neutral
(N/A)
26.56
(15.35)
-42.21% Details
3/2/2022 CONMED CNMD New Coverage Neutral
(N/A)
144.55
(96.89)
-32.97% Details
3/2/2022 Shockwave Medical SWAV New Coverage Buy
(N/A)
178.80
(198.62)
11.09% Details
3/2/2022 Insulet Corporation PODD New Coverage Buy
(N/A)
260.84
(226.46)
-13.18% Details
3/2/2022 Outset Medical Inc. OM New Coverage Buy
(N/A)
43.61
(15.65)
-64.11% Details
3/2/2022 Inspire Medical Systems INSP New Coverage Buy
(N/A)
242.30
(189.15)
-21.94% Details
3/2/2022 DexCom DXCM New Coverage Buy
(N/A)
408.41
(77.63)
-80.99% Details
3/2/2022 Axonics Modulation Technologies Inc. AXNX New Coverage Buy
(N/A)
57.38
(57.96)
1.01% Details
3/2/2022 Zimmer Biomet ZBH New Coverage Underperform
(N/A)
123.39
(107.27)
-13.06% Details
3/2/2022 Edwards Lifesciences EW New Coverage Neutral
(N/A)
112.37
(97.39)
-13.33% Details
3/2/2022 Becton Dickinson BDX New Coverage Neutral
(N/A)
271.28
(251.80)
-7.18% Details
3/2/2022 Stryker SYK New Coverage Buy
(N/A)
263.35
(203.86)
-22.59% Details
3/2/2022 Medtronic, Inc. MDT New Coverage Buy
(N/A)
104.99
(91.38)
-12.96% Details
3/2/2022 Intuitive Surgical ISRG New Coverage Buy
(N/A)
290.33
(206.10)
-29.01% Details
3/2/2022 Boston Scientific BSX New Coverage Buy
(N/A)
44.17
(38.01)
-13.95% Details
3/2/2022 Baxter International BAX New Coverage Buy
(N/A)
84.97
(65.49)
-22.93% Details
3/2/2022 Abbott Labs ABT New Coverage Buy
(N/A)
120.62
(110.22)
-8.62% Details
1/6/2021 DexCom DXCM Downgrade Underperform
(Buy)
368.75
(77.63)
-78.95% Details
6/17/2020 DexCom DXCM Maintain Buy
(N/A)
 
 
  Details
12/18/2019 DexCom DXCM Maintain Buy
(N/A)
 
 
  Details
6/7/2019 DexCom DXCM Maintain Buy
(N/A)
 
 
  Details
9/20/2018 Tandem Diabetes Care TNDM Maintain Neutral
(N/A)
 
 
  Details
8/24/2018 Tandem Diabetes Care TNDM Upgrade Neutral
(Underperform)
38.61
(61.81)
60.09% Details